Generic placeholder image

Coronaviruses

Editor-in-Chief

ISSN (Print): 2666-7967
ISSN (Online): 2666-7975

Research Article

Small Interference RNA Encapsulated in Liposomes: An Effective Strategy for In vitro Inhibition of Sars-CoV-2 Load

In Press, (this is not the final "Version of Record"). Available online 01 February, 2024
Author(s): Joao Pedro Viana Rodrigues, Vanessa Pinheiro Gonçalves, Francisco Dantas Lourenço, Ronaldo Bragança Martins, Felipe Rocha do Nascimento, Eurico Arruda, Larissa Deadame de Figueiredo Nicolete and Roberto Nicolete*
Published on: 01 February, 2024

Article ID: e010224226639

DOI: 10.2174/0126667975279621240124115409

Price: $95

Abstract

Background: The pressing need for effective SARS-CoV-2 antiviral medicines has driven research into innovative therapeutic techniques. RNA interference with small interfering RNAs (siRNAs) has shown promise as an antiviral treatment.

Objective: We evaluated the effectiveness of lipid-based nanoparticles as a viable delivery platform for siRNA-based approach against SARS-CoV-2 in vitro infection.

Methods: Liposomes were fabricated by microfluidics to incorporate SARS-CoV-2-specific siRNAs based on conserved sections of the Spike protein coding sequence. Nanoparticle tracking analysis was used to evaluate the nanoparticles' physicochemical features. VERO cell lines infected with SARS-CoV-2 were used to test the efficiency of siRNA-loaded liposomes. RT-PCR was used to determine the viral load by quantifying the SARS-CoV-2 genome.

Results: The results showed that liposomes efficiently decreased viral load in infected cells with good physicochemical features, such as a mean particle size of about 180 nm, zeta potential of +2.5 mV and encapsulation efficiency (53.6%).

Conclusion: These findings imply that lipid-based nanoparticles might be a targeted delivery strategy for siRNA-based approaches.


Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy